STAA
STAAR Surgical Company24.80
+1.24+5.26%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
1.22BP/E (TTM)
-Basic EPS (TTM)
-1.96Dividend Yield
0%Recent Filings
8-K
8-K
8-K
Q3 sales up 6.9% on China payment
STAAR Surgical reported preliminary Q3 2025 net sales of $94.7 million, up 6.9% from $88.6 million last year, boosted by $25.9 million from a deferred December 2024 China shipment paid in full this quarter. Growth outside China rose 7.7%, but new orders there dipped due to distributor inventory cuts. This timing quirk lifted results ahead of the October 23 stockholder vote on the Alcon merger. China inventory now aligns at six months.
10-Q
Q2 FY2025 results
STAAR Surgical's Q2 FY2025 net sales fell 55% y/y to $44.3M, driven by a sharp drop in China from distributor inventory drawdowns, though Americas and EMEA grew 10% and 11% respectively; gross margin slipped to 74.0% from 79.2% on lower volumes. Restructuring charges of $27.9M YTD fueled an operating loss of $87.4M and net loss of $71.0M, or $(1.44) diluted EPS on 49.4M shares—anti-dilutive due to the loss. Cash climbed to $167.1M with $22.8M from investing, while free cash flow stood negative at $(36.2M) (derived). Post-quarter, Alcon announced a $28/share merger, pending approvals. Uncertainty lingers over China tariffs.
8-K
Q2 sales plunge on China inventory
STAAR Surgical reported Q2 2025 net sales of $44.3 million, down 55% year-over-year from $99.0 million, hammered by a planned inventory drawdown in China that slashed regional revenue to $5.3 million. Yet excluding China, sales climbed 10% to $39.0 million, fueled by gains in other markets, while gross margin held at 74.0% amid volume dips but cost controls. Restructuring charges of $5.2 million contributed to a $16.8 million net loss. Pending Alcon acquisition disrupts operations. Cash stands at $189.9 million.
IPO
Website
Employees
Sector
Industry
ALC
Alcon Inc.
79.02-0.17
BLCO
Bausch + Lomb Corporation
16.98-0.11
COO
The Cooper Companies, Inc.
81.04-0.49
ISRG
Intuitive Surgical, Inc.
554.58-4.94
LNSR
LENSAR, Inc.
12.06+0.54
POCI
Precision Optics Corporation, I
4.20-0.07
RXST
RxSight, Inc.
12.76+0.24
SGHT
Sight Sciences, Inc.
8.39+0.08
SSII
SS Innovations International In
5.50+0.41
STSS
Sharps Technology Inc.
2.22+0.00